Cargando…
Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial
The Women's Health Study trial previously reported no overall effect of low-dose aspirin (100 mg every other day) on invasive breast cancer over an average of 10 years of treatment. The present subgroup analyses further show no effects by tumour characteristics at diagnosis, suggesting that low...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266841/ https://www.ncbi.nlm.nih.gov/pubmed/18268496 http://dx.doi.org/10.1038/sj.bjc.6604240 |